During a business results briefing, it was reported that Kyorin Pharmaceuticals is developing iPS cell-derived alveolar epithelial cells, jointly with Kyoto University, to explore drug discovery targets
Nikkei Biotech news release, May 19, 2017
Kyorin Pharmaceuticals and Kyoto University explore cell therapy of pulmonary fibrosis